Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The U.K. Medicines and Healthcare Regulatory Agency (MHRA) has green-lighted two separate Phase 3 trials conducted by Compass Pathways (NASDAQ: CMPS) for Treatment-Resistant Depression and Awakn Life Sciences (OTCMKTS: AWKNF) for Severe Alcohol Use Disorder (SAUD).
Haverhill Mental Health Action Group says it is here to help, as more people are recorded as having mental health problems suffolknews.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from suffolknews.co.uk Daily Mail and Mail on Sunday newspapers.
The Rhode Island Department of Environmental Management (DEM) is conducting fall trout stocking, in advance of the Columbus Day holiday weekend, in selected areas in Rhode Island from Thursday, Sept. …